...
首页> 外文期刊>Acute Medicine & Surgery >Epidemiology and volume‐outcome relationship of extracorporeal membrane oxygenation for respiratory failure in Japan: A retrospective observational study using a national administrative database
【24h】

Epidemiology and volume‐outcome relationship of extracorporeal membrane oxygenation for respiratory failure in Japan: A retrospective observational study using a national administrative database

机译:流行病学和体外结果与日本呼吸衰竭呼吸氧合的含量:使用国家行政数据库的回顾性观测研究

获取原文
           

摘要

Aim To describe the epidemiology of patients on extracorporeal membrane oxygenation (ECMO) and investigate the possible association between outcomes for respiratory ECMO patients and hospital volume of ECMO treatment for any indications. Methods Using data from the Diagnosis Procedure Combination database, a nationwide Japanese inpatient database, between 1 July 2010 and 31 March 2018, we identified inpatients aged ≥18?years who underwent ECMO. Institutional case volume was defined as the mean annual number of ECMO cases; eligible patients were categorized into institutional case volume tertile groups. The primary outcome was in‐hospital mortality. For ECMO patients with respiratory failure, the association between institutional case volume group and in‐hospital mortality rate was analyzed using a multilevel logistic regression model including multiple imputation. Results Extracorporeal membrane oxygenation was carried out on 25,384 patients during the study period; of those, 1,227 cases were for respiratory failure. Respiratory cases were categorized into low‐ (<8 cases/year), medium‐ (8–16 cases/year), and high‐volume groups (≥17 cases/year). The overall in‐hospital mortality rate for respiratory ECMO was 62.5% in low‐, 54.7% in medium‐, and 50.4% in high‐volume institutions. With reference to low‐volume institutions, the adjusted odds ratios (95% confidence interval) of the medium‐ and high‐volume institutions for in‐hospital mortality were 0.72 (0.50–1.04;P ?=?0.082) and 0.65 (0.45–0.95;P ?=?0.024), respectively. Conclusions The present study showed that accumulating the experience of using ECMO for any indications could positively affect the outcome of ECMO treatment for respiratory failure, which suggests the effectiveness of consolidating ECMO cases in high‐volume centers in Japan. Pursuing the centralization of respiratory extracorporeal membrane oxygenation (ECMO) patients remains an issue in Japan. The present study showed that accumulating the experience of using ECMO for any indications could positively affect the outcome of ECMO treatment for respiratory failure, which suggests the effectiveness of consolidating ECMO cases in high‐volume centers in Japan.
机译:目的描述患者体外膜氧合(ECMO)的流行病学,并研究任何适应症的呼吸道ECMO患者结果与ECMO治疗患者的结果之间的可能关联。方法使用来自诊断程序组合数据库的数据,全国日本住院数据库,2010年7月1日至2018年3月31日,我们确定了≥18岁的住院患者达到了ECMO的年龄段。制度案例量被定义为ECMO病例的平均年数;符合条件的患者被分类为机构案例体积的Tertile组。主要结果是在医院的死亡率。对于患有呼吸衰竭的ECMO患者,使用包括多重估算的多级逻辑回归模型分析制度案例体积组和住院内死亡率之间的关联。结果在研究期间对25,384名患者进行体外膜氧合;其中1,227例用于呼吸衰竭。呼吸病例分为低(<8例/年),中等(8-16例/年)和大容量群(≥17例/年)。呼吸道ECMO的整体内部死亡率率低于62.5%,中等 - 中等 - 54.7%,高批量生产50.4%。参考低批量机构,医院内部死亡率的调整后的大量比率(95%置信区间)为0.72(0.50-1.04; P?= 0.082)和0.65 (0.45-0.95; p?= 0.024)。结论本研究表明,累积使用ECMO对任何适应症的经验可以积极影响ECMO治疗呼吸衰竭的结果,这表明巩固日本大批量中心的ECMO病例的有效性。追求呼吸体外膜氧合(ECMO)患者的集体仍然是日本问题。本研究表明,累积使用ECMO对任何适应症的经验可以积极影响呼吸衰竭的ECMO治疗的结果,这表明在日本巩固高批量中心巩固ECMO病例的有效性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号